BioRem Inc. (CVE:BRM – Free Report) – Research analysts at Cormark dropped their FY2025 EPS estimates for shares of BioRem in a research report issued on Tuesday, April 22nd. Cormark analyst N. Boychuk now expects that the company will earn $0.21 per share for the year, down from their previous forecast of $0.22. Cormark also issued estimates for BioRem’s FY2026 earnings at $0.27 EPS.
BioRem Price Performance
Shares of BRM opened at C$1.96 on Wednesday. The stock has a market capitalization of C$32.14 million, a PE ratio of 6.06 and a beta of 0.85. The company has a 50 day moving average price of C$2.35 and a 200-day moving average price of C$2.69. The company has a debt-to-equity ratio of 37.47, a quick ratio of 1.08 and a current ratio of 1.91. BioRem has a fifty-two week low of C$1.84 and a fifty-two week high of C$3.45.
About BioRem
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
Recommended Stories
- Five stocks we like better than BioRem
- Best Aerospace Stocks Investing
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- What Are Trending Stocks? Trending Stocks Explained
- Why Smart Investors Don’t Panic in Election Season
- ETF Screener: Uses and Step-by-Step Guide
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.